Conditions: Post-ERCP Acute Pancreatitis
Keywords: Post ERCP acute pancreatitis Post Fine Needle Aspiration (FNA) acute pancreatitis Indomethacin Rectal Non Steroidal Anti-Inflammatory Drugs (NSAIDs)
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 449
Healthy volunteers: no

Brief summary:
The purpose of this study is to assess whether peri-procedural administration of rectal indomethacin, compared to placebo, can reduce the incidence of post-ERCP pancreatitis.

Detailed description:

Arms:
arm 1: Indomethacin 100 mg Per Rectum (PR) x 1 in peri-procedural period arm 2: Placebo suppositories (#2)

Interventions: intervention 1: Indomethacin intervention 2: Placebo
Intervention descriptions: intervention 1: 100 mg Indomethacin PR x 1 intervention 2: None

Protocol document: